Skip Navigation

2010.05.06 Weekly Broadcast Email

The following updates were made to the CCCWFU CCOP Research Base website for the week of May 3, 2010.



Adverse Events:


The following adverse events were reported during the month of April

97405: 12 & 13

97106: 5




Accrual Totals:


In the month of April, 15 patients were accrued to CCCWFU CCOP Research Base trials. Ochsner Clinic Foundation and CTSU were tied for the top accruing site with 4 patients each. See the Research Base website <> spotlight section for further information.






The results from several recently closed Research Base studies have been accepted for presentation at ASCO (June 4-8, 2010). Those studies include:


97202: Randomized Double-Blind Placebo-Controlled Study of Oral Coenzyme Q10 to Relieve Self-Reported Cancer Treatment Related Fatigue in Breast Cancer Patients


 98308: A Phase III Randomized, Double-Blind, Placebo Controlled Trial of North American Ginseng Extract (CVT-E002;COLD-FX®) to Prevent Respiratory Infection and Reduce Antibiotic Use in Patients with Chronic Lymphocytic Leukemia.


Congratulations to those study PIs



Sarah Hahne will be out of the office on maternity leave through June 9.  Please contact Lisa Autry Hawkins at (336/716-0891)in her absence.


Lisa Autry-

Quick Reference

Research Base

Phone 336-716-0891
Fax 336-716-6275


Medical Center Boulevard, 525@Vine 4th floor
Box 573152
Winston-Salem, NC 27157
Find A Doctor Ways to Give
Last Updated: 05-11-2015
Six Wake Forest Baptist Specialties Earn U.S. News RankingsComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsMagnet Hospital RecognitionJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.